Publications

This page lists the scientific publications related to the EVAg project. The default filter is set to "publications for which the research was funded by the EVAg project". You can change this filter to another value by picking a different filter from the drop-down list and clicking on the "Apply" button.

346 publications displayed

Datesort ascending Name Journal EVAg
Apr 2021 The stability of an isolate of the SARS-CoV-2 B.1.1.7 lineage in aerosols is similar to three earlier isolates The Journal of Infectious Diseases Research funded by EVAg, Published by EVAg end-user
Apr 2021 Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen Journal of Clinical Medicine Research funded by EVAg, Published by EVAg partner
Apr 2021 In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy Journal of Infection Research funded by EVAg, Published by EVAg partner
Apr 2021 Extremely potent human monoclonal antibodies from COVID-19 convalescent patients Cell Research funded by EVAg, Published by EVAg end-user
Mar 2021 COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020 Biomolecules Research funded by EVAg, Published by EVAg partner
Mar 2021 COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice Journal of Virology Research funded by EVAg, Published by EVAg end-user
Mar 2021 An Integrated Molecular Approach to Untangling Host–Vector–Pathogen Interactions in Mosquitoes (Diptera: Culicidae) From Sylvan Communities in Mexico Frontiers in Veterinary Science Research funded by EVAg, Published by EVAg partner
Mar 2021 Accuracy of serological testing for SARS‐CoV‐2 antibodies: First results of a large mixed‐method evaluation study Allergy Research funded by EVAg, Published by EVAg end-user
Mar 2021 Use of convalescent serum reduces severity of COVID-19 in nonhuman primates Cell Reports Research funded by EVAg, Published by EVAg end-user
Mar 2021 Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples Clinical Microbiology and Infection Research funded by EVAg, Published by EVAg partner
Mar 2021 Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies Journal of Immunological Methods Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Feb 2021 Evaluation of a Trio Toscana Virus Real-Time RT-PCR Assay Targeting Three Genomic Regions within Nucleoprotein Gene Pathogens Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Feb 2021 Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing International Journal of Environmental Research and Public Health Research funded by EVAg, Published by EVAg partner
Feb 2021 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19 PLoS ONE Research funded by EVAg, Published by EVAg partner
Feb 2021 Coronavirus replication–transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit Proceedings of the National Academy of Sciences Research funded by EVAg, Published by EVAg end-user
Feb 2021 Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus Viruses Research funded by EVAg, Published by EVAg partner
Feb 2021 Identification, Isolation, and Characterization of an Ectromelia Virus New Strain from an Experimental Mouse Virologica Sinica Research funded by EVAg, Published by EVAg partner
Feb 2021 Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models Cell Host & Microbe Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Jan 2021 Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection Viruses Research funded by EVAg, Published by EVAg partner
Jan 2021 Seroprevalence of Toscana Virus and Sandfly Fever Sicilian Virus in European Bat Colonies Measured Using a Neutralization Test Viruses Research funded by EVAg, Published by EVAg partner
Jan 2021 A nidovirus perspective on SARS-CoV-2 Biochemical and Biophysical Research Communications Research funded by EVAg, Published by EVAg partner
Jan 2021 SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring Science of The Total Environment Research funded by EVAg, Published by EVAg partner
Jan 2021 Identification of mosquitoes (Diptera: Culicidae) from Mexico State, Mexico using morphology and COI DNA barcoding Acta Tropica Research funded by EVAg, Published by EVAg partner
Jan 2021 Establishment of an African green monkey model for COVID-19 and protection against re-infection Nature Immunology Research funded by EVAg, Published by EVAg end-user
Jan 2021 Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort Emerging Microbes & Infections Research funded by EVAg, Published by EVAg end-user
Dec 2020 Modeling intra-mosquito dynamics of Zika virus and its dose-dependence confirms the low epidemic potential of Aedes albopictus PLoS Pathogens Research funded by EVAg, Published by EVAg partner
Dec 2020 Vertebrate-Aedes aegypti and Culex quinquefasciatus (Diptera)-arbovirus transmission networks: Non-human feeding revealed by meta-barcoding and next-generation sequencing PLoS Neglected Tropical Diseases Research funded by EVAg, Published by EVAg partner
Dec 2020 SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma Research funded by EVAg, Published by EVAg end-user
Dec 2020 Bat-Borne Coronaviruses in Jordan and Saudi Arabia: A Threat to Public Health? Viruses Research funded by EVAg, Published by EVAg partner
Dec 2020 Small Interfering RNAs Are Highly Effective Inhibitors of Crimean-Congo Hemorrhagic Fever Virus Replication In Vitro Molecules Research funded by EVAg, Published by EVAg end-user
Dec 2020 Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly PLoS Pathogens Research funded by EVAg, Published by EVAg partner
Dec 2020 Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis Nature Research funded by EVAg, Published by EVAg partner
Dec 2020 Syncytia formation by SARS‐CoV‐2‐infected cells The EMBO Journal Research funded by EVAg, Published by EVAg partner
Dec 2020 The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis Biopreservation and Biobanking Research funded by EVAg, Published by EVAg partner
Dec 2020 A novel Schmallenberg virus subunit vaccine candidate protects IFNAR-/- mice against virulent SBV challenge Scientific Reports Research funded by EVAg, Published by EVAg end-user
Dec 2020 Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis Nature Communications Research funded by EVAg, Published by EVAg partner
Dec 2020 A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics Nature Communications Research funded by EVAg, Published by EVAg end-user
Dec 2020 Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase Virology Journal Research funded by EVAg, Published by EVAg end-user
Dec 2020 Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients Nature Communications Research funded by EVAg, Published by EVAg partner
Nov 2020 The newly introduced SARS-CoV-2 variant A222V is rapidly spreading in Lazio region, Italy Research funded by EVAg, Published by EVAg partner
Nov 2020 Proteotyping SARS-CoV-2 Virus from Nasopharyngeal Swabs: A Proof-of-Concept Focused on a 3 Min Mass Spectrometry Window Journal of Proteome Research Research funded by EVAg, Published by EVAg end-user
Nov 2020 Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients European Heart Journal - Cardiovascular Pharmacotherapy Research funded by EVAg, Published by EVAg end-user
Nov 2020 A simple method for detection of a novel coronavirus (SARS‐CoV‐2) using one‐step RT‐PCR followed by restriction fragment length polymorphism Journal of Medical Virology Research funded by EVAg, Published by EVAg end-user
Oct 2020 Quantifying and mapping the burden of human and animal rabies in Iraq PLoS Neglected Tropical Diseases Research funded by EVAg, Published by EVAg partner
Oct 2020 Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay Viruses Research funded by EVAg, Published by EVAg partner
Oct 2020 Detection of Usutu virus infection in wild birds in the United Kingdom, 2020 Eurosurveillance Research funded by EVAg, Published by EVAg partner
Oct 2020 Differential pathogenesis of Usutu virus isolates in mice PLoS Neglected Tropical Diseases Research funded by EVAg, Published by EVAg end-user
Oct 2020 Anti-Zika virus and anti-Usutu virus activity of human milk and its components PLoS Neglected Tropical Diseases Research funded by EVAg, Published by EVAg end-user
Oct 2020 Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics Open Forum Infectious Diseases Research funded by EVAg, Published by EVAg partner
Oct 2020 Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses Antiviral Research Research funded by EVAg, Published by EVAg end-user

Pages